Postoperative Surveillance for Recurrent Malignant Disease
The goals of initial therapy for thyroid cancer are to remove or destroy all evidence of disease while minimizing treatment-related side effects and unnecessary therapies. This initial management, if successful, should result in decreasing local or distant recurrence as well as disease-specific mortality. While certainly not a new concept, the last several years have seen a renewed interest in a risk-adapted approach to the management of thyroid cancer in which the extent and intensity of initial therapy is tailored according to individualized risk estimates of recurrence and mortality. Following thyroid surgery (either total thyroidectomy or hemi-thyroidectomy), patients continue a risk-adapted approach to ongoing thyroid cancer management based on standardized clinicopathologic factors that predict the risk of recurrence and/or mortality. In this approach, the risks and benefits of potential additional therapies are balanced against the specific risks of recurrence, mortality, and response to therapy for individual patients.
KeywordsThyroid Cancer Papillary Thyroid Carcinoma National Comprehensive Cancer Network National Comprehensive Cancer Network Differentiate Thyroid Cancer
- 5.Tuttle RM (2010) National comprehensive cancer network, clinical practice guidelines in oncology, thyroid cancer. http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf. Cited 8 Apr 2010
- 29.Tuttle RM, Tala H, Shah J et al (2010) Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system. Thyroid 20(12):1341–1349PubMedCrossRefGoogle Scholar
- 37.Hay ID, Bergstralh EJ, Goellner JR et al (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114(6):1050–1057, discussion 1057–1058PubMedGoogle Scholar
- 40.Greene FL, Page DL, Fleming ID (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New YorkGoogle Scholar